Almost three years after signing the lease, Amgen is opening its second-largest R&D facility, representing a significant pharma footprint in San Francisco, according to a release Thursday. The new ...
AstraZeneca is again building in a city called Cambridge. Shortly after completing its late, over-budget R&D center in Cambridge, U.K., the British pharma has begun work across the Atlantic on a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback